1 insider bought €3.2M of shares over the last 90 days, the latest filed 20 Sept 2026.
Sigma Healthcare Limited, founded in 1912, is a listed company based in Australia. Its directors and officers file their transactions with ASX. The last twelve months, up to 18 October 2026, brought 2 filings signed by 1 insider.
Every open-market trade in the period is a purchase: 2 purchases worth €3.2M, from 1 insider, and not a single sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Among those who bought: 1 senior executive. The filings include the largest purchase, €3.2M, on 20 September 2026.
With 2 filings in twelve months, the company is quieter than the median of 3 filings across the 2,532 companies we follow on the same exchange. Over the whole record (from 2026), the tally stands at 2 purchases and no sales.
The clock since the last published purchase (20 September 2026) now reads 27 days.
This summary is built from ASX disclosures alone and does not predict where the share price will go.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
· cache
Sigma Healthcare Limited is an Australian company specializing in the distribution of pharmaceutical and healthcare products. It primarily operates in the Australian market, providing services to pharmacies and healthcare facilities.
Headquarters: Australia · Founded: 1912 · Wikipedia article
Source: Wikidata (CC0).